LRMR Larimar Therapeutics Inc

$LRMR My wife died from Friedreicks Ataxia in 2024 and they don't mention that part often, the death from the disease. The person loses control of their breathing and its like being suffocated over and over and over until eventually the diaphragm loses compete coordination and the patient dies from lack of oxygen, its fckn horrible!

$LRMR My 'radical' trading strategy for Larimar: Add under $4 and then trim above $12 . Even at $12 the company isn't even being valued at 1/5TH of what REATA sold for.

$LRMR Phase 3 starts within a month, other modules submitted probably a month after that... FDA submission acceptance less than a month after that... pieces falling into place soon...

$LRMR It's funny... the shorts are really in a pickle here... how do they cover a 12% short position when only around 2-4% available that isn't owned by either tutes or insiders... so they try to do wacky things like bouncing the SP around to try to stoke retailers fears a little (evidently not working) and other goofy things like trying to play with the 'sentiment score' ... Twits shows a very bearish sentiment even though there hasn't been a single bearish comment here in over a month, lol. When the shorts finally figure the math out, they'll realize the best exit strategy is to cover ASAP... Time to wake up, shorts.

$LRMR some fine day I will awake to the price of $LRMR exploding upwards. Until then, patience grasshopper

$LRMR Larimar Therapeutics assumed with an Outperform at Leerink 11:12 AM Leerink analyst Basma Radwan assumed coverage of Larimar Therapeutics with an Outperform rating and a price target of $13, up from $12. The company's only product, nomlabofusp, is differentiated by directly addressing the underlying FXN deficiency in Friedriech's ataxias, says the analyst, who believes nomlabofusp's benefit-risk profile is "favorable" and that the current BLA package has "a credible path to accelerated approval."

$LRMR they are trying to frustrate the impatient. Keep adding. One fine day it will be buy out

$LRMR ADAGE, AIGH sold out and Millenium sold 64%, Point 72 sold 87%. Defilde, James Flynn and Blue Owl accumulated. Point 72 is a fund I follow.

$LRMR Don't understand why it gets smacked at the open and then has to claw back all day. Can we just get some decent gains already 🙏